Atlas Trials

Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis

Clinical trial NCT03855956 · COMPLETED

Trial details

NCT number
NCT03855956
Sponsor
Kaleido Biosciences
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Early Cirrhosis
Start date
2019-02-27
Primary completion
2019-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.